Center-Authored Papers

Filters: Author is Tiffany Butts  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2013
Swearingen B, Chang J, Graves S, Butts T, Storb R, Mathes DW.  2013.  A clinically applicable tolerance protocol to induce tolerance to vascularized composite allografts without the need for persistent donor cell chimerism. Journal of the American College of Surgeons. 217:S92-S92. Abstract
2014
Swearingen B, Chang J, Butts T, Graves S, Storb R, Mathes DW.  2014.  Extended Immunosuppressive Therapy in a Non-Myeloablative Conditioning Regimen: Achieving Tolerance in VCA While Reducing Risk of GVHD. Transplantation. 98:406-407. Abstract
Swearingen B, Chang J, Butts T, Graves S, Storb R, Mathes DW.  2014.  Achieving Tolerance in a Mismatched VCA Transplant While Reducing The Risk of GVHD: Goal of Transient Chimerism.. Transplantation. 98:409-410. Abstract
August 2014
Swearingen B, Chang J, Butts T, Graves S, Storb R, Mathes DW.  2014.  Extended Immunosuppressive Therapy in a Non-Myeloablative Conditioning Regimen: Achieving Tolerance in VCA While Reducing Risk of GVHD. Transplantation. 98:406-407. Abstract
Swearingen B, Chang J, Butts T, Graves S, Storb R, Mathes DW.  2014.  Achieving Tolerance in a Mismatched VCA Transplant While Reducing The Risk of GVHD: Goal of Transient Chimerism.. Transplantation. 98:409-410. Abstract
Clinical Research Division
Swearingen B, Chang J, Graves S, Butts T, Storb R, Mathes DW.  2013.  A clinically applicable tolerance protocol to induce tolerance to vascularized composite allografts without the need for persistent donor cell chimerism. Journal of the American College of Surgeons. 217:S92-S92. Abstract
Swearingen B, Chang J, Butts T, Graves S, Storb R, Mathes DW.  2014.  Extended Immunosuppressive Therapy in a Non-Myeloablative Conditioning Regimen: Achieving Tolerance in VCA While Reducing Risk of GVHD. Transplantation. 98:406-407. Abstract
Swearingen B, Chang J, Butts T, Graves S, Storb R, Mathes DW.  2014.  Achieving Tolerance in a Mismatched VCA Transplant While Reducing The Risk of GVHD: Goal of Transient Chimerism.. Transplantation. 98:409-410. Abstract
December 2013
Swearingen B, Chang J, Graves S, Butts T, Storb R, Mathes DW.  2013.  A clinically applicable tolerance protocol to induce tolerance to vascularized composite allografts without the need for persistent donor cell chimerism. Journal of the American College of Surgeons. 217:S92-S92. Abstract
Surgery
Swearingen B, Chang J, Graves S, Butts T, Storb R, Mathes DW.  2013.  A clinically applicable tolerance protocol to induce tolerance to vascularized composite allografts without the need for persistent donor cell chimerism. Journal of the American College of Surgeons. 217:S92-S92. Abstract